Pharmacokinetics comparison of solifenacin tartrate and solifenacin succinate: a randomized, open-label, single-dose, 2-way crossover study in healthy male volunteers

Solifenacin is a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms. Solifenacin tartrate is a newly developed salt formulation of solifenacin. This study compared the pharmacokinetic and safety properties after single-dose administration of solifenacin tartrate (t...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Yu-mi, Jeon, Ji-Young, Moon, Seol Ju, Jung, Jina, Son, Hankil, Kim, Min-Gul
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Korean Society for Clinical Pharmacology and Therapeutics 2018
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989256/
https://www.ncbi.nlm.nih.gov/pubmed/32055552
http://dx.doi.org/10.12793/tcp.2018.26.2.73

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6989256/
https://www.ncbi.nlm.nih.gov/pubmed/32055552
http://dx.doi.org/10.12793/tcp.2018.26.2.73

Ejemplares similares